<DOC>
	<DOCNO>NCT01710332</DOCNO>
	<brief_summary>A preliminary study determine safety efficacy intravitreal aflibercept injection patient persistent central serous chorioretinopathy .</brief_summary>
	<brief_title>The Safety &amp; Efficacy Intravitreal Aflibercept Injection Patients With Persistent Central Serous Chorioretinopathy</brief_title>
	<detailed_description>Intravitreal Aflibercept Injection Persistent Central Serous Chorioretinopathy : A Prospective Pilot Study</detailed_description>
	<mesh_term>Central Serous Chorioretinopathy</mesh_term>
	<criteria>Pretreatment acuity 20/40 20/320 Macular fluid optical coherence tomography great 3 month Leakage fluorescein angiography Willing able comply clinic visit studyrelated procedure Provide sign informed consent Treatment CSCR study eye ( antiVEGF , PDT , laser ) within three month prior study enrollment Presence choroidal neovascularization enrollment image Prior vitrectomy study eye Presence substantial ocular disease ( CSCR ) may compromise vision study eye /or confound interpretation data ; e.g . substantial cataract , advance glaucoma , optic neuritis , optic neuropathy atrophy , mark macular atrophy , ocular vascular occlusion , history retinal detachment , uveitis , viral form chorioretinitis , etc . History rhegmatogenous retinal detachment macular hole ( Stage 3 4 ) study eye Uncontrolled glaucoma study eye ( defined IOP â‰¥ 25 mmHg despite treatment antiglaucoma medication ) Active ocular infection inflammation study eye Active infectious conjunctivitis , keratitis , scleritis , endophthalmitis either eye Prior treatment systemic antiVEGF agent Cerebrovascular accident myocardial infarction within precede 6 month . History allergy fluorescein , povidone iodine ( Betadine ) aflibercept Participation study investigational drug device within 30 day prior potential enrollment study Pregnant breastfeed woman Sexually active men* woman childbearing potential** unwilling practice adequate contraception study ( adequate contraceptive measure include stable use oral contraceptive prescription pharmaceutical contraceptive 2 menstrual cycle prior screen ; intrauterine device [ IUD ] ; bilateral tubal ligation ; vasectomy ; condom plus contraceptive sponge , foam , jelly , diaphragm plus contraceptive sponge , foam , jelly ) Contraception require men document vasectomy . Postmenopausal woman must amenorrheic least 12 month order consider child bear potential . Pregnancy test contraception require woman document hysterectomy tubal ligation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Persistent</keyword>
	<keyword>Central</keyword>
	<keyword>Serous</keyword>
	<keyword>Chorioretinopathy</keyword>
	<keyword>Regeneron</keyword>
	<keyword>CSR</keyword>
	<keyword>CSCR</keyword>
</DOC>